Exaccord Dosage & Drug Information

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.

Core Prescribing Info

Contents

Exemestane

Indications/Uses

Adjuvant treatment of postmenopausal women w/ oestrogen receptor +ve invasive early breast cancer (EBC) following 2-3 yr of initial adjuvant tamoxifen therapy. Advanced breast cancer in women w/ natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy.

Dosage/Direction for Use

Adult & elderly 25 mg tab once daily. Patient w/ EBC Continue exemestane until 5-yr completion of combined sequential adjuvant hormonal therapy (tamoxifen followed by exemestane) or earlier if tumor relapse occurs. Patient w/ advanced breast cancer Continue exemestane until tumor progression is evident.

Administration

Should be taken with food.

Contraindications

Hypersensitivity.

MIMS Class

Cancer Hormone Therapy

ATC Classification

L02BG06 - exemestane ; Belongs to the class of enzyme inhibitors. Used in treatment of neoplastic diseases.

Regulatory Classification

POM

Presentation/Packing

Form

Exaccord FC tab 25 mg

Packing/Price

1's

Exaccord

exemestane

Manufacturer:

Intas Pharmaceuticals